0001055726-23-000043.txt : 20230517
0001055726-23-000043.hdr.sgml : 20230517
20230517161239
ACCESSION NUMBER: 0001055726-23-000043
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230515
FILED AS OF DATE: 20230517
DATE AS OF CHANGE: 20230517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sumner Michael John
CENTRAL INDEX KEY: 0001936799
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14888
FILM NUMBER: 23931832
MAIL ADDRESS:
STREET 1: 660 W. GERMANTOWN PIKE
STREET 2: SUITE 110
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001055726
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330969592
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8584103134
MAIL ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP
DATE OF NAME CHANGE: 20050404
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP
DATE OF NAME CHANGE: 20011116
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD
DATE OF NAME CHANGE: 19980213
4
1
wk-form4_1684354347.xml
FORM 4
X0407
4
2023-05-15
0
0001055726
INOVIO PHARMACEUTICALS, INC.
INO
0001936799
Sumner Michael John
660 W. GERMANTOWN PIKE
SUITE 110
PLYMOUTH MEETING
PA
19462
0
1
0
0
Chief Medical Officer
0
Restricted Stock Unit
2023-05-15
4
A
0
85878
0
A
Common Stock
85878
85878
D
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 85,878 restricted stock units is as follows: 28,626 shares will vest on May 15, 2024; 28,626 shares will vest on May 15, 2025; and 28,626 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
This grant was made under the 2016 Omnibus Incentive Plan.
/s/ Michael John Sumner
2023-05-17